KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Cvs Health (CVS) Accumulated Depreciation & Amortization (2016 - 2025)

Cvs Health (CVS) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $23.4 billion as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Accumulated Depreciation & Amortization rose 13.28% year-over-year to $23.4 billion, compared with a TTM value of $23.4 billion through Dec 2024, up 13.28%, and an annual FY2024 reading of $23.4 billion, up 13.28% over the prior year.
  • Accumulated Depreciation & Amortization was $23.4 billion for Q4 2024 at Cvs Health, up from $20.7 billion in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $23.4 billion in Q4 2024 and bottomed at $4.2 billion in Q4 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $11.5 billion, with a median of $4.5 billion recorded in 2021.
  • The sharpest move saw Accumulated Depreciation & Amortization dropped 5.87% in 2022, then skyrocketed 387.38% in 2023.
  • Year by year, Accumulated Depreciation & Amortization stood at $4.4 billion in 2020, then grew by 1.6% to $4.5 billion in 2021, then dropped by 5.87% to $4.2 billion in 2022, then skyrocketed by 387.38% to $20.7 billion in 2023, then grew by 13.28% to $23.4 billion in 2024.
  • Business Quant data shows Accumulated Depreciation & Amortization for CVS at $23.4 billion in Q4 2024, $20.7 billion in Q4 2023, and $4.2 billion in Q4 2022.